More about
Adenocarcinoma
Clinical Guidance
Non-Small Cell Lung Cancer
Clinical Examples
Non-Small Cell Lung Cancer
Clinical Guidance
Non-Small Cell Lung Cancer
Presentation and Diagnosis
Staging
Clinical Guidance
Non-Small Cell Lung Cancer
Presentation and Diagnosis
Presentation, Diagnosis and Assessment
Clinical Guidance
Non-Small Cell Lung Cancer
Overview
Overview of Non-Small Cell Lung Cancer
News
July 23, 2024
3 min read
Save
Occupational benzene exposure heightens lung cancer likelihood
Clinical Guidance
Immuno-Oncology
Clinical Examples
Gastric Adenocarcinoma
Clinical Guidance
Genomics
Clinical Examples
Gastric Adenocarcinoma
News
March 29, 2024
5 min read
Save
Why am I so darn tired?
News
May 17, 2021
2 min read
Save
Q&A: non-endoscopic detection for BE, esophageal adenocarcinoma
News
September 11, 2019
3 min read
Save
Speaker: Rationale exists to test CAR T-cell therapy in KRAS-mutated lung cancer
BARCELONA — Enriched cell surface expression of mesothelin in KRAS-mutated adenocarcinoma and supporting preclinical evidence suggest chimeric antigen receptor T-cell therapy targeting mesothelin may be feasible and efficacious for this group of patients, according to a presentation at International Association for the Study of Lung Cancer World Conference on Lung Cancer.